Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI).
Por:
Lorente-Rovira E, Eva Maria Grasa Bello, Ochoa S, Corripio I, Peláez T, López-Carrilero R, Gutiérrez-Gea Á, Morano-Guillén M, Villagrán JM, Bartels-Velthuis AA, Jenner JA and Sanjuán J
Publicada:
1 oct 2022
Ahead of Print:
31 may 2020
Categoría:
Psychiatry and mental health
Resumen:
INTRODUCTION: An updated summary of the most used instruments assessing auditory hallucinations in population with psychosis, allows us to underline the scarceness and need of Spanish versions of important instruments. The aim of the study is to examine the psychometric characteristics of two different and complementary instruments for assessing auditory hallucinations, the Spanish version of the Auditory Vocal Hallucination Scale (AVHRS) and the Spanish version of the Positive and Useful Voices Inquiry (PUVI). MATERIALS AND METHODS: A sample of 68 patients from four different centres, with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder presenting with auditory hallucinations were included. Apart from the AVHRS and the PUVI, the Psychotic Symptom Rating Scales-Auditory Hallucinations subscale (PSYRATS-AH) and the Positive and Negative Syndrome Scale (PANSS) were also administered to all patients, plus an acceptability questionnaire. RESULTS: The Spanish version of the AVHRS showed a good internal consistency, a moderate to high inter-rater reliability, a medium to moderate test-retest reliability, and a good convergent and discriminant validity. The Spanish version of the PUVI showed a good internal consistency and a heterogeneous, but in general moderate, test-retest reliability. CONCLUSIONS: The Spanish versions of the AVHRS and the PUVI have good psychometric properties and are well accepted among patients.
Filiaciones:
Lorente-Rovira E:
Hospital Clínico, Valencia, Spain
INCLIVA, Valencia, Spain
CIBERSAM, Madrid, Spain
Eva Maria Grasa Bello:
CIBERSAM, Madrid, Spain
Department of Psychiatry, Biomedical Research Institute Sant Pau (IIB-SANT PAU, Hospital Sant Pau, Barcelona, Spain
Universitat Autònoma de Barcelona (UAB), Spain
Ochoa S:
Parc Sanitari Sant Joan de Deu, Barcelona, Spain
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
CIBERSAM, Madrid, Spain
Corripio I:
CIBERSAM, Madrid, Spain
Department of Psychiatry, Biomedical Research Institute Sant Pau (IIB-SANT PAU, Hospital Sant Pau, Barcelona, Spain
Universitat Autònoma de Barcelona (UAB), Spain
Peláez T:
CIBERSAM, Madrid, Spain
Parc Sanitari Sant Joan de Deu, Barcelona, Spain
López-Carrilero R:
CIBERSAM, Madrid, Spain
Parc Sanitari Sant Joan de Deu, Barcelona, Spain
Gutiérrez-Gea Á:
Hospital Jerez de la Frontera, Servicio Andaluz de Salud, Cádiz, Spain
Morano-Guillén M:
Hospital Jerez de la Frontera, Servicio Andaluz de Salud, Cádiz, Spain
Villagrán JM:
Hospital Jerez de la Frontera, Servicio Andaluz de Salud, Cádiz, Spain
Bartels-Velthuis AA:
University of Groningen, the Netherlands
University Medical Center Groningen, University Center for Psychiatry, Groningen, the Netherlands
Jenner JA:
Jenner Consult, Haren, the Netherlands Groningen, the Netherlands
Sanjuán J:
Hospital Clínico, Valencia, Spain
INCLIVA, Valencia, Spain
CIBERSAM, Madrid, Spain
Faculty of Medicine, Valencia, Spain
Green Published
|